Sunday 22 October 2017
Contact US    |    Archive
PR
1 months ago

Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo® 32mg Extended Release Tablets

DUBLIN, Sept. 21, 2017 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced it has

Read on the original site


Hashtags:   

Perrigo

 | 

Announces

 | 

FDA

 | 

Final

 | 

Approval

 | 

For

 | 

Its

 | 

Rated

 | 

Generic

 | 

Version

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries